Eric J. Fues and Kyle W. Howarth of Finnegan discuss decisions exploring the multi-pronged analysis in patent law for ...

The nation’s highest patent court will rehear a case Thursday asking it to restrict the kinds of evidence expert witnesses ...

In Kroy IP Holdings, LLC v. Groupon, Inc., 127 F.4th 1376 (Fed. Cir. 2025), the Federal Circuit held that patentees in district court are ...

President Donald Trump’s pick to lead the US Patent and Trademark Office is setting off alarm bells for tech companies and ...

As part of a global web of patent litigation over COVID-19 vaccines and mRNA technology, Pfizer and its partner BioNTech ...

Kyle W. Howarth is an associate at Finnegan, where he focuses on patent litigation in federal courts as well as post-grant ...

Moderna's legal win boosts stock but highlights mRNA technology struggles. Discover why MRNA stock may not sustain long-term ...

On Tuesday, the Trump administration nominated John Squires, a partner in the New York office of Dilworth Paxon LLP, as director of the United ...

Axsome Therapeutics AXSM announced that it has entered into a settlement agreement with Hikma Pharmaceuticals related to ...

This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state ...

Five years after the start of the pandemic, the fight over who owns the underlying technologies that made the Covid-19 ...

The settlement agreement resolves the patent litigation brought by Axsome on Hikma for submitting an abbreviated new drug application to the FDA, seeking marketing approval for a generic version ...